Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
hsa-miR-93-5p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
Smad7
Cancer name
Prolactinoma
Cancer site
Pituitary Gland
Treatment type
Chemotherapy
Drug
Bromocriptine
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-93-5p could enhance the drug resistance of prolactinoma cells by regulation of TGF-Ī²1/Smad3-dependent fibrosis.
Tissue resource
prolactinoma samples
Experiment
Western blot,Luciferase reporter assay
Institute
the First Affiliated Hospital, Sun-Yet Sen University
Country
China
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.